Comprehensive Supply of Oncology and Supportive Care Medications

This tender, initiated by the Department of Military Affairs under the Ministry of Defence, seeks quotations for a comprehensive supply of Oncology Drugs. The bid number for this opportunity is GEM/2026/B/8181725, with bidding open from 30-10-2026 at 10:38 AM until 13-11-2026 at 11:00 AM. The Bill of Quantities (BOQ) encompasses a wide array of critical chemotherapy and supportive care medications, including but not limited to Cyclosporin A Micro Emulsion, Cyclophosphamide, Cytosine Arabinoside, Dacarbazine, Daunorubicin, Etoposide, Fludarabine, Hydroxyurea, Idarubicin, Doxorubicin HCl, Gemcitabine, Imatinib Mesylate, Melphalan, Mercaptopurine, Vincristine Sulphate, Thalidomide, Lenalidomide, Al-trans-retinoic acid, Dasatinib, Decitabine, Azacitidine, Eltrombopag, Zolendronic Acid, Anti-thymocytic globulin (Equine), Fosaprepitant, Bendamustine, Methotrexate, Acalabrutinib, Cytarabine, Voriconazole, Human Fibrinogen Concentrate, Prothrombin complex concentrate (500 IU Four Factor), and Factor VIII (250 Mg, Plasma Derived, Recombinant FactorVIII with extended half-life, Turoctocog alfa pegol 1000 IU). The total quantity for these essential pharmaceuticals across all listed items is 67612. The procurement is being managed by the Indian Army, located in Panchkula.